ARGERIS N. KARABELAS

Insider Reports History

Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ARGERIS N. KARABELAS:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bausch Health Companies Inc. Director Common Shares, No Par Value 123,715 $992,194 $8.02 24 Jun 2022 Direct
REGENXBIO Inc. Director Common Stock 19,054 $151,860 $7.97 30 May 2025 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 39,815 30 May 2025 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 30,000 01 Jul 2024 Direct

Insider Reports Filed by ARGERIS N. KARABELAS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGNX REGENXBIO Inc. 30 May 2025 2 $0 4 Director 03 Jun 2025, 16:31
RGNX REGENXBIO Inc. 01 Oct 2024 3 -$63,452 4 Director 02 Oct 2024, 16:31
RGNX REGENXBIO Inc. 03 Sep 2024 4 -$77,988 4 Director 04 Sep 2024, 20:20
RGNX REGENXBIO Inc. 01 Aug 2024 7 -$97,580 4 Director 05 Aug 2024, 18:39
RGNX REGENXBIO Inc. 29 Jul 2024 3 -$25,355 4 Director 30 Jul 2024, 17:01
RGNX REGENXBIO Inc. 01 Jul 2024 3 -$75,091 4 Director 03 Jul 2024, 07:55
RGNX REGENXBIO Inc. 31 May 2024 2 $0 4 Director 04 Jun 2024, 16:42
RGNX REGENXBIO Inc. 02 Jun 2023 2 $0 4 Director 06 Jun 2023, 17:12
BHC Bausch Health Companies Inc. 24 Jun 2022 1 $0 4 Director 28 Jun 2022, 16:38
RGNX REGENXBIO Inc. 03 Jun 2022 2 $0 4 Director 07 Jun 2022, 16:20
RGNX REGENXBIO Inc. 04 Jun 2021 1 $0 4 Director 08 Jun 2021, 16:20